Birdwatch Note
2024-11-13 11:52:33 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
ファクトチェック済のミスリード情報です。 https://litmus-factcheck.jp/2024/11/4359/ 本治験は、プラセボ群にもワクチンを投与する前の有効性の評価期間(day1～day92)に①ワクチン群が５人（コロナ死１）、②プラセボ群は１６名（コロナ死９）で②プラセボ群の方が３倍以上死亡しています(各群約８千人の参加者、③④その後の約４か月で両群で１３名が死亡）。全ての死亡にワクチンとの因果関係は見られていません。 原典は下記です。 https://www.pmda.go.jp/drugs/2023/P20231122002/780009000_30500AMX00282_A100_3.pdf#page=29 上記記事の補足として、治験の参加者の２４％は基礎疾患保持者です。 https://www.pmda.go.jp/drugs/2023/P20231122002/780009000_30500AMX00282_A100_3.pdf#page=45 高齢者は17%です。 https://www.nature.com/articles/s41467-024-47905-1/tables/1 ベトナムは年間、千人中７人が亡くなる国でそれを大幅に下回っています。 https://data.worldbank.org/indicator/SP.DYN.CDRT.IN?locations=VN
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1856654479275573508
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1856666459608666498
- noteId - 1856666459608666498
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1731498753823
- tweetId - 1856654479275573508
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- ファクトチェック済のミスリード情報です。 https://litmus-factcheck.jp/2024/11/4359/ 本治験は、プラセボ群にもワクチンを投与する前の有効性の評価期間(day1～day92)に①ワクチン群が５人（コロナ死１）、②プラセボ群は１６名（コロナ死９）で②プラセボ群の方が３倍以上死亡しています(各群約８千人の参加者、③④その後の約４か月で両群で１３名が死亡）。全ての死亡にワクチンとの因果関係は見られていません。 原典は下記です。 https://www.pmda.go.jp/drugs/2023/P20231122002/780009000_30500AMX00282_A100_3.pdf#page=29 上記記事の補足として、治験の参加者の２４％は基礎疾患保持者です。 https://www.pmda.go.jp/drugs/2023/P20231122002/780009000_30500AMX00282_A100_3.pdf#page=45 高齢者は17%です。 https://www.nature.com/articles/s41467-024-47905-1/tables/1 ベトナムは年間、千人中７人が亡くなる国でそれを大幅に下回っています。 https://data.worldbank.org/indicator/SP.DYN.CDRT.IN?locations=VN
Note Ratings
| rated at | rated by | |
| 2024-11-14 17:55:09 -0600 | Rating Details | |
| 2024-11-14 17:44:58 -0600 | Rating Details | |
| 2024-11-14 14:34:49 -0600 | Rating Details | |
| 2024-11-14 08:47:45 -0600 | Rating Details | |
| 2024-11-13 21:51:32 -0600 | Rating Details | |
| 2024-11-13 21:03:20 -0600 | Rating Details | |
| 2024-11-13 18:53:04 -0600 | Rating Details | |
| 2024-11-13 18:05:33 -0600 | Rating Details | |
| 2024-11-13 18:05:33 -0600 | Rating Details | |
| 2024-11-13 17:13:10 -0600 | Rating Details | |
| 2024-11-13 16:55:18 -0600 | Rating Details | |
| 2024-11-13 16:30:35 -0600 | Rating Details | |
| 2024-11-13 16:14:08 -0600 | Rating Details | |
| 2024-11-13 14:49:58 -0600 | Rating Details | |
| 2024-11-13 13:38:04 -0600 | Rating Details | |
| 2024-11-13 13:27:14 -0600 | Rating Details | |
| 2024-11-13 13:08:18 -0600 | Rating Details | |
| 2024-11-13 12:46:46 -0600 | Rating Details | |
| 2024-11-13 12:36:20 -0600 | Rating Details | |
| 2024-11-13 10:42:49 -0600 | Rating Details | |
| 2024-11-13 10:39:32 -0600 | Rating Details | |
| 2024-11-13 09:28:47 -0600 | Rating Details | |
| 2024-11-13 09:12:06 -0600 | Rating Details | |
| 2024-11-13 08:42:04 -0600 | Rating Details | |
| 2024-11-13 08:37:46 -0600 | Rating Details | |
| 2024-11-13 08:01:37 -0600 | Rating Details | |
| 2024-11-13 07:34:06 -0600 | Rating Details | |
| 2024-11-13 06:52:53 -0600 | Rating Details | |
| 2024-11-13 06:46:00 -0600 | Rating Details | |
| 2024-11-13 06:43:24 -0600 | Rating Details | |
| 2024-11-13 06:39:21 -0600 | Rating Details | |
| 2024-11-13 06:29:31 -0600 | Rating Details | |
| 2024-11-13 06:25:37 -0600 | Rating Details | |
| 2024-11-13 06:24:58 -0600 | Rating Details | |
| 2024-11-13 06:22:16 -0600 | Rating Details | |
| 2024-11-13 06:21:37 -0600 | Rating Details | |
| 2024-11-13 06:20:48 -0600 | Rating Details | |
| 2024-11-13 06:18:22 -0600 | Rating Details | |
| 2024-11-13 06:15:05 -0600 | Rating Details | |
| 2024-11-13 06:13:58 -0600 | Rating Details | |
| 2024-11-13 06:13:30 -0600 | Rating Details | |
| 2024-11-13 06:12:31 -0600 | Rating Details | |
| 2024-11-13 06:12:10 -0600 | Rating Details | |
| 2024-11-13 06:11:36 -0600 | Rating Details | |
| 2024-11-13 06:11:05 -0600 | Rating Details | |
| 2024-11-13 06:10:49 -0600 | Rating Details | |
| 2024-11-13 06:09:20 -0600 | Rating Details | |
| 2024-11-13 06:09:05 -0600 | Rating Details | |
| 2024-11-13 06:08:42 -0600 | Rating Details | |
| 2024-11-13 06:08:28 -0600 | Rating Details | |
| 2024-11-13 06:07:36 -0600 | Rating Details | |
| 2024-11-13 06:06:58 -0600 | Rating Details | |
| 2024-11-13 06:05:44 -0600 | Rating Details | |
| 2024-11-13 06:02:03 -0600 | Rating Details | |
| 2024-11-13 06:01:52 -0600 | Rating Details | |
| 2024-11-16 06:29:28 -0600 | Rating Details | |
| 2024-11-15 06:37:22 -0600 | Rating Details | |
| 2024-11-17 18:50:29 -0600 | Rating Details | |
| 2024-11-15 11:04:36 -0600 | Rating Details | |
| 2024-11-15 07:00:50 -0600 | Rating Details | |
| 2024-11-14 06:40:56 -0600 | Rating Details | |
| 2024-11-13 23:18:49 -0600 | Rating Details | |
| 2024-11-13 23:08:29 -0600 | Rating Details | |
| 2024-11-13 22:17:39 -0600 | Rating Details | |
| 2024-11-13 18:54:54 -0600 | Rating Details | |
| 2024-11-13 18:19:43 -0600 | Rating Details | |
| 2024-11-13 17:34:21 -0600 | Rating Details | |
| 2024-11-13 17:24:22 -0600 | Rating Details | |
| 2024-11-13 16:38:22 -0600 | Rating Details | |
| 2024-11-13 16:15:58 -0600 | Rating Details | |
| 2024-11-13 16:15:15 -0600 | Rating Details | |
| 2024-11-13 16:10:19 -0600 | Rating Details | |
| 2024-11-13 16:08:54 -0600 | Rating Details | |
| 2024-11-13 15:14:34 -0600 | Rating Details | |
| 2024-11-13 13:01:07 -0600 | Rating Details | |
| 2024-11-13 08:30:25 -0600 | Rating Details | |
| 2024-11-13 08:10:02 -0600 | Rating Details | |
| 2024-11-13 07:06:29 -0600 | Rating Details | |
| 2024-11-13 06:51:49 -0600 | Rating Details | |
| 2024-11-13 06:30:07 -0600 | Rating Details | |
| 2024-11-13 06:24:41 -0600 | Rating Details | |
| 2024-11-13 06:21:33 -0600 | Rating Details | |
| 2024-11-13 06:09:49 -0600 | Rating Details | |
| 2024-11-14 14:25:23 -0600 | Rating Details | |
| 2024-11-14 10:20:36 -0600 | Rating Details | |
| 2024-11-14 02:32:24 -0600 | Rating Details | |
| 2024-11-14 00:44:40 -0600 | Rating Details | |
| 2024-11-13 22:51:03 -0600 | Rating Details | |
| 2024-11-13 20:04:10 -0600 | Rating Details | |
| 2024-11-13 20:03:12 -0600 | Rating Details | |
| 2024-11-13 19:47:35 -0600 | Rating Details | |
| 2024-11-13 19:35:56 -0600 | Rating Details | |
| 2024-11-13 18:58:18 -0600 | Rating Details | |
| 2024-11-13 18:04:01 -0600 | Rating Details | |
| 2024-11-13 17:51:44 -0600 | Rating Details | |
| 2024-11-13 17:36:37 -0600 | Rating Details | |
| 2024-11-13 16:52:29 -0600 | Rating Details | |
| 2024-11-13 16:19:06 -0600 | Rating Details | |
| 2024-11-13 15:27:54 -0600 | Rating Details | |
| 2024-11-13 14:10:21 -0600 | Rating Details | |
| 2024-11-13 12:48:41 -0600 | Rating Details | |
| 2024-11-13 10:27:50 -0600 | Rating Details | |
| 2024-11-13 09:54:17 -0600 | Rating Details | |
| 2024-11-13 09:41:30 -0600 | Rating Details | |
| 2024-11-13 09:17:56 -0600 | Rating Details | |
| 2024-11-13 07:40:00 -0600 | Rating Details | |
| 2024-11-13 07:18:10 -0600 | Rating Details | |
| 2024-11-13 07:00:44 -0600 | Rating Details | |
| 2024-11-13 06:52:36 -0600 | Rating Details | |
| 2024-11-13 06:46:36 -0600 | Rating Details | |
| 2024-11-13 06:38:35 -0600 | Rating Details | |
| 2024-11-13 06:35:30 -0600 | Rating Details | |
| 2024-11-13 06:35:02 -0600 | Rating Details | |
| 2024-11-13 06:33:19 -0600 | Rating Details | |
| 2024-11-13 06:31:23 -0600 | Rating Details | |
| 2024-11-13 06:29:57 -0600 | Rating Details | |
| 2024-11-13 06:17:25 -0600 | Rating Details | |
| 2024-11-13 06:16:26 -0600 | Rating Details | |
| 2024-11-13 06:11:41 -0600 | Rating Details | |
| 2024-11-13 06:08:47 -0600 | Rating Details | |
| 2024-11-13 06:08:25 -0600 | Rating Details | |
| 2024-11-13 06:08:25 -0600 | Rating Details | |
| 2024-12-25 17:56:39 -0600 | Rating Details |